Increased Exhaled 8-Isoprostane and Interleukin-6 in Patients with Helicobacter pylori Infection

Helicobacter

Volumn 21, Issue 5, 2016, Pages 389-394

  Yildirim, Zeki ^a   Bozkurt, Bulent ^b   Ozol, Duygu ^b   Armutcu, Ferah ^c   Akgedik, Recep ^d   Karamanli, Harun ^e   Kizilirmak, Deniz ^g   İkizek, Mustafa ^f  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b TURGUT OZAL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d ORDU UNIVERSITY   (Turkey)

^e Ataturk Chest Disease and Chest Surgery Research and Education Hospital   (Turkey)

^f Tatvan State Hospital   (Turkey)

^g HAKKARI STATE HOSPITAL   (Turkey)

Author keywords

airway; Helicobacter pylori; inflammation; oxidative stress

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; C REACTIVE PROTEIN; INTERLEUKIN 6;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG FUNCTION TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPIROMETRY; THORAX RADIOGRAPHY;

EID: 84986882197     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12302     Document Type: Article

References (32)

1. Suerbaum S, Michetti P. Helicobacter pylori Infection. N Engl J Med 2002;347:1175–86.
2. Monzon H, Forne M, Esteve M, Rosinach M, Loras C, Espinos JC, Viver JM, Salas A, Fernandez-Banares F. Helicobacter pylori infection as a cause of iron deficiency anaemia of unknown origin. World J Gastroenterol 2013;19:4166–71.
3. Hughes WS. An hypothesis: the dramatic decline in heart attacks in the United States is temporally related to the decline in duodenal ulcer disease and Helicobacter pylori infection. Helicobacter 2014;19:239–41.
4. Koc C, Arikan OK, Atasoy P, Aksoy A. Prevalence of Helicobacter pylori in patients with nasal polyps: a preliminary report. Laryngoscope 2004;114:1941–4.
5. Morinaka S, Ichimiya M, Nakamura H. Detection of Helicobacter pylori in nasal and maxillary sinus specimens from patients with chronic sinusitis. Laryngoscope 2003;113:1557–63.
6. Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and Extragastric Diseases. Helicobacter 2014;19(Suppl 1):52–8.
7. Yemisen M, Mete B, Kanbay A, Balkan II, Ozaras R. The Role of Helicobacter pylori in Upper Respiratory System Infections: is it More Than Colonization? Curr Infect Dis Rep 2012;14:128–36.
8. Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med 2007;101:203–9.
9. Roussos A, Philippou N, Krietsepi V, Anastasakou E, Alepopoulou D, Koursarakos P, Iliopoulos I, Gourgoulianis K. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease. Respir Med 2005;99:279–84.
10. Kanbay M, Gur G, Akcay S, Yilmaz U. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med 2005;99:1213–6.
11. Tsang KW, Lam WK, Chan KN, Hu W, Wu A, Kwok E, Zheng L, Wong BC, Lam SK. Helicobacter pylori sero-prevalence in asthma. Respir Med 2000;94:756–9.
12. Zhou X, Wu J, Zhang G. Association between Helicobacter pylori and asthma: a meta-analysis. Eur J Gastroenterol Hepatol 2013;25:460–8.
13. Gencer M, Ceylan E, Yildiz Zeyrek F, Aksoy N. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests. Respiration 2007;74:170–5.
14. Ishida Y, Suzuki K, Taki K, Niwa T, Kurotsuchi S, Ando H, Iwase A, Nishio K, Wakai K, Ito Y, Hamajima N. Significant association between Helicobacter pylori infection and serum C-reactive protein. Int J Med Sci 2008;24:5.
15. Emelyanov A, Fedoseev G, Abulimity A, Rudinski K, Fedoulov A, Karabanov A, Barnes PJ. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001;120:1136–9.
16. Hanazawa T, Kharitonov SA, Barnes PJ. Increased Nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000;162:1273–6.
17. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216–20.
18. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expiratory air for oxidation products. Am J Respir Crit Care Med 2002;166:S31–7.
19. Yildirim Z, Sogut S, Koksal N, Kilic T. Increased nitrite levels in exhaled breath condensate in asthma-like syndrome induced by occupational sulfur dioxide exposure. Turk J Med Sci 2012;42:425–31.
20. Karamanlı H, Özol D, Ugur KS, Yıldırım Z, Armutçu F, Bozkurt B, Yigitoglu R. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 2014;18:251–6.
21. Schaper F, Rose-John S. Interleukin-6: Biology, signaling and strategies of blockade. Cytokine Growth Factor Rev 2015;26:475–87.
22. Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 2003;12:1299–302.
23. Malfertheiner MV, Kandulski A, Schreiber J, Malfertheiner P. Helicobacter pylori infection and the respiratory system: a systematic review of the literature. Digestion 2011;84:212–20.
24. Strachan DP. Non-gastrointestinal consequences of Helicobacter pylori infection. Br Med Bull 1998;54:87–93.
25. Odenbreit S, Linder S, Gebert-Vogl B, Rieder G, Moran AP, Haas R. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 2006;11:196–207.
26. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005;45:1219–22.
27. Siva R, Birring SS, Berry M, Rowbottom A, Pavord ID. Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology 2013;18:728–31.
28. Antus B, Kardos Z. Oxidative Stress in COPD: molecular Background and Clinical Monitoring. Curr Med Chem 2015;22:627–50.
29. Ischiropoulous H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998;356:1–11.
30. Özol D, Karamanli H, Uysal S, Yığıtoğlu MR, Yildirim Z. Airway inflammation and tiotropium treatment in stable COPD patients. Turk J Med Sci 2014;44:804–8.
31. Engler DB, Reuter S, van Wijck Y, Urban S, Kyburz A, Maxeiner J, Martin H, Yogev N, Waisman A, Gerhard M, Cover TL. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc Natl Acad Sci USA 2014;111:11810–5.
32. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Müller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011;121:3088–93.